Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: SW stock price vs SLGN: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at SLGN's multiple
Needs Annual EPS, SLGN P/E.
Implied fair value · at SW's multiple
Needs Annual EPS, SW P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Higher is better
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Smurfit Westrock plc · implied price per share
Reporting currency could not be verified.
SILGAN HOLDINGS INC · implied price per share
Reporting currency could not be verified.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
SW · not enough data.
SLGN · not enough data.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe SW can sustainably improve EBITDA margin and reduce net debt/EBITDA from 11.5x toward SLGN-like levels, then the current weakness may be a hold-to-buy opportunity; otherwise, the data favors reducing exposure because SW trades at a much richer P/E and EV/EBITDA than SLGN despite weaker profitability and higher financial risk.
SW’s current price of $43.33 versus an implied P/E value of $20.16 suggests a -53.5% downside to SLGN-based valuation estimate. The gap is driven mainly by SW’s much richer P/E and EV/EBITDA multiples versus SLGN, despite similar EV/Revenue levels.
Supporting Metrics
